FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a preparatory kit presented to a patient before administering a therapeutic botulinum toxin. The declared kit contains an additive in the form of capsules or tablets, which comprise zinc ions in the organic or inorganic form in a sufficient dose of 10mg to 400mg of elementary zinc a day, and a phytase additive in an amount of 0.8-10,000 units sufficient to be administered together with the ion zinc additive for the period of zinc ion load. The preparatory kit also comprises a package insert providing the patient with recommendations to administer the zinc ion additives and to reduce the phytate dose.
EFFECT: zinc dose provides activating the therapeutic botulinum toxin for the period of zinc ion load before initiating the therapy with the therapeutic botulinum toxin.
4 cl, 1 tbl, 3 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
BIOPREPARATIONS COMPOSITIONS FOR INTRAVESICAL INSTILLATION | 2015 |
|
RU2720991C2 |
METHOD OF TREATING MUSCULAR DYSTONIES | 2017 |
|
RU2704815C2 |
BOTULOTOXIN DOSAGE REGIMEN FOR PREVENTION OF CHRONIC MIGRAINE | 2011 |
|
RU2549981C9 |
METHODS OF TREATING CHRONIC NEUROGENIC INFLAMMATION BY MODIFIED CLOSTRIDIAL TOXIN | 2010 |
|
RU2568844C2 |
IMPROVED USE OF BOTULINUM NEUROTOXIN IN THE TREATMENT OF SIALORRHEA | 2018 |
|
RU2778481C2 |
THERAPEUTIC USE OF AT LEAST ONE BOTULINUM NEUROTOXIN FOR MANAGING PAIN INDUSED BY AT LEAST ONE ANTI-CANCER AGENT | 2007 |
|
RU2483747C2 |
USE OF BOTULINUM NEUROTOXINS IN TREATMENT | 2018 |
|
RU2766147C2 |
IMPROVED BLADDER INJECTION SCHEME FOR ADMINISTRATION OF BOTULINUM TOXINS | 2017 |
|
RU2741966C2 |
TREATMENT WITH APPLICATION OF BOTULINIC TOXIN | 2004 |
|
RU2350348C2 |
SUPPRESSION OF ALLODYNIA INDUCED BY BONE CANCER | 2019 |
|
RU2791640C2 |
Authors
Dates
2015-02-10—Published
2010-06-23—Filed